BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 24754377)

  • 21. Cognitive impairment: dementia and Alzheimer's disease.
    Larson EB; Kukull WA; Katzman RL
    Annu Rev Public Health; 1992; 13():431-49. PubMed ID: 1599598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New and emerging treatments for Alzheimer's disease.
    Corbett A; Smith J; Ballard C
    Expert Rev Neurother; 2012 May; 12(5):535-43. PubMed ID: 22550982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Gustavsson A; Green C; Jones RW; Förstl H; Simsek D; de Reydet de Vulpillieres F; Luthman S; Adlard N; Bhattacharyya S; Wimo A
    Alzheimers Dement; 2017 Mar; 13(3):312-321. PubMed ID: 28063281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Commentary on "A roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Who may benefit from disease-modifying studies in Alzheimer's disease?
    Gauthier S; Poirier J
    Alzheimers Dement; 2009 Mar; 5(2):147-8. PubMed ID: 19328447
    [No Abstract]   [Full Text] [Related]  

  • 29. Toward better Alzheimer's research information sources for the public.
    Payne PW
    Am J Alzheimers Dis Other Demen; 2013 Mar; 28(2):108-10. PubMed ID: 23423479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological of and risk factors for Alzheimer's disease: a review.
    Povova J; Ambroz P; Bar M; Pavukova V; Sery O; Tomaskova H; Janout V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Jun; 156(2):108-14. PubMed ID: 22837131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevention therapeutics of dementia.
    Schneider LS
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S122-30. PubMed ID: 18631988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pivotal moment in Alzheimer's disease and dementia: how global unity of purpose and action can beat the disease by 2025.
    Vradenburg G
    Expert Rev Neurother; 2015 Jan; 15(1):73-82. PubMed ID: 25576089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perestroika in pharma: evolution or revolution in drug development?
    FitzGerald GA
    Mt Sinai J Med; 2010; 77(4):327-32. PubMed ID: 20687177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational research in genomics of Alzheimer's disease: a review of current practice and future perspectives.
    Mihaescu R; Detmar SB; Cornel MC; van der Flier WM; Heutink P; Hol EM; Rikkert MG; van Duijn CM; Janssens AC
    J Alzheimers Dis; 2010; 20(4):967-80. PubMed ID: 20182048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The world of dementia beyond 2020.
    Brodaty H; Breteler MM; Dekosky ST; Dorenlot P; Fratiglioni L; Hock C; Kenigsberg PA; Scheltens P; De Strooper B
    J Am Geriatr Soc; 2011 May; 59(5):923-7. PubMed ID: 21488846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug discovery and the prevention of Alzheimer's disease.
    Fillit H
    Alzheimers Dement; 2008 Jan; 4(1 Suppl 1):S26-8. PubMed ID: 18631996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiology of age-related dementias in the Third World and aetiological clues of Alzheimer's disease.
    Osuntokun BO; Ogunniyi AO; Lekwauwa GU; Oyediran AB
    Trop Geogr Med; 1991 Oct; 43(4):345-51. PubMed ID: 1812598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.
    Cummings JL; Ringman J; Metz K
    J Alzheimers Dis; 2010; 19(2):375-88. PubMed ID: 20110588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.